novartis ag-reg (NOVN:SIX Swiss Ex)
Former Chief Executive Officer of Sandoz Germany, Novartis AG
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Mr. Hans-Helmut Fabry served as Chief Executive Officer of Sandoz Germany at Novartis AG (Formerly Sandoz Germany). Mr. Fabry served as Country Head of Sandoz Germany & Hexal and Member of Supervisory Board at Sandoz International GmbH. He served as Chief Executive Officer of Sandoz Germany at Sandoz International GmbH since July 2007. In this role, Mr. Fabry oversees all operations for the German Sandoz companies and is responsible for growing the business and related ...
Lichtstrasse 35Phone: 41 61 324 11 11
Basel, Basel-Stadt 4056
Board Members Memberships*There is no Board Members Memberships data available.
Harvard Business School
Westfälische Wilhelms-Universität Münster
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Alan George Lafley||Chairman, Chief Executive Officer, President and Member of Proxy Committee|
The Procter & Gamble Company
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Kenneth C. Frazier||Chairman and Chief Executive Officer|
Merck & Co. Inc.
|Serge Weinberg||Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee|
|€700.0K||Compensation as of Fiscal Year 2013.|